VideaHealth key facts
as of Oct 2026- Developer of an artificial intelligence technology designed to detect pathologies in dental imaging automatically.
- VideaHealth is valued at approximately $400.0M as of Oct 2026, set at its later-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $65.4M across 4 recorded rounds; the latest was Later Stage VC (Series B) ($40.0M) in Jan 2025.
- Notable investors include Spark Capital, 515 Ventures, Avenir Growth Capital, Pillar VC, BAM Ventures — 14 tracked in total.
- VideaHealth has filed 3 Form Ds with the SEC since 2019, most recently Mar 2022 ($20.0M sold to 6 investors).
- Status: Privately Held (backing).
Valued at $400.0M at its later-stage round, Jan 2025. Nothing has traded since.
- ·The complete investor list: 14 names
- ·Watch VideaHealth: the Monday email on marks, rounds and moves
VideaHealth funding rounds
4 roundsWho backs VideaHealth
14+VideaHealth valuation
VideaHealth was valued at $400 million at its later-stage round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has VideaHealth raised?
VideaHealth has raised $65.4 million across 4 recorded rounds since 2018. The largest was a $5.4 million early-stage round in Sep 2019; the most recent was a $40 million Series B in Jan 2025.
VideaHealth has filed 3 Form Ds with the SEC since 2019, most recently in Mar 2022 ($20 million sold to 6 investors).
VideaHealth investors
14 investors are on record for VideaHealth, including Spark Capital, 515 Ventures, Avenir Growth Capital and Pillar VC. By type, the record holds 4 venture capital firms, 1 angel investor and 1 growth equity firm. The Series B in Jan 2025 drew 6 investors.
Comparable companies
Comparable decision/risk analysis names by valuation on PrivateMarketView: HeartFlow (NAS: HTFL) ($1.5 billion), Anumana ($580 million) and Inductive Bio ($80 million).
About VideaHealth
Developer of an artificial intelligence technology designed to detect pathologies in dental imaging automatically. The company's technology improves disease detection compared to the average unaided dentist and increases case acceptance with a real-time second opinion and advanced visual case presentation, and also manages and grows dental practices with actionable insights, enabling dental practices and insurers to unlock new value through artificial intelligence-driven image analysis and analytics that streamlines diagnoses, treatment planning, and claims processing.
- Industry
- Decision/Risk Analysis
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2018
- Employees
- 161
- Website
- videa.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.